Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) — Results from the Multicentre Indian Pancreatic & amp; Periampullary Adenocarcinoma Project (MIPPAP) Study

ConclusionsThe MIPPAP study shows that resectable PDACs in India have survivals at par with previously published data. Adjuvant therapy was administered in 75% patients. Adjuvant radiotherapy does not seem to add to survival after R0 resection.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research